DCOne-derived dendritic cells therapy(Mendus)

N/A

Report date: 2024/06/14 17:39:23

Base Information

Drug NameDCOne-derived dendritic cells therapy(Mendus)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySweden

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMendus AB

China Registration ClassN/A

Active CompaniesMendus AB

Inactive CompaniesN/A

Active IndicationsHematologic Neoplasms

Inactive IndicationsN/A

ATC CodeN/A